Treatment of acute delirium in a patient with parkinson’s disease by transfer to the intensive care unit and administration of dexmedetomidine

Morgan Lombardo, Amanda Dipiazza, Kelly Rippey, Naomi Lubarr, Elana Clar, Hooman Azmi

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

The treatment of delirium or psychosis in patients with Parkinson’s disease (PD) can be complicated by the limited number of pharmacological agents that can be used in this population. Typical and atypical antipsychotics are contraindicated, as they can worsen motor symptoms. The treatment of acute delirium is even more complicated in the hospital setting, as many medications deemed safer in this population are only available in oral form. We present a case of acute delirium in a patient with PD, likely precipitated by a polypharmacy interaction of new medications, that was successfully managed by transferring the patient to the intensive care unit and administering dexmedetomidine for 72 hours.

Original languageEnglish
Pages (from-to)159-162
Number of pages4
JournalJournal of Movement Disorders
Volume13
Issue number2
DOIs
StatePublished - May 2020
Externally publishedYes

Keywords

  • AaDelirium
  • Dexmedetomidine
  • Parkinson’s disease
  • Treatment

Fingerprint

Dive into the research topics of 'Treatment of acute delirium in a patient with parkinson’s disease by transfer to the intensive care unit and administration of dexmedetomidine'. Together they form a unique fingerprint.

Cite this